Patients researching stent options sometimes come across the terms cobalt-chromium vs stainless steel coronary stents and wonder what the material difference actually means for treatment. Both alloys have a long track record in interventional cardiology, but they differ in mechanical properties that influence strut thickness, flexibility, and how the stent behaves once implanted. This article explains the general distinctions; the specific stent material used in any procedure is selected by the treating cardiologist.
What Is a Stainless Steel Coronary Stent?
Stainless steel was one of the original materials used in early coronary stent development and remains in use today in certain stent platforms, including some INVAMED ATLAS stainless-steel systems.
- Well-established material with a long clinical history in cardiovascular devices
- Generally requires relatively thicker struts to achieve adequate radial strength compared to newer alloys
- Offers reliable structural integrity and deliverability for routine percutaneous coronary interventions
- Often positioned as a cost-conscious option while maintaining dependable mechanical performance
What Is a Cobalt-Chromium Coronary Stent?
Cobalt-chromium alloys, such as the L605 alloy used in the INVAMED ATLAS platform, represent a newer generation of stent material widely adopted in contemporary drug-eluting stent design.
- Higher inherent strength relative to volume allows manufacturers to design thinner struts (in the range of 60 microns for the ATLAS platform) while maintaining comparable or greater radial strength than thicker stainless-steel struts
- Thinner struts are generally associated with improved vessel wall coverage, flexibility, and trackability through tortuous or complex anatomy
- Frequently used as the base platform for laser-cut, open-cell stent designs paired with drug-eluting coatings
- Radiopaque markers, often platinum-iridium, are typically integrated at the stent extremities to support fluoroscopic visualization during placement
How Do the Two Materials Compare?
| Property | Stainless Steel | Cobalt-Chromium |
|---|---|---|
| Typical strut thickness | Relatively thicker | Thinner (e.g., ~60 µm on ATLAS CoCr) |
| Radial strength per unit thickness | Lower | Higher |
| Flexibility/deliverability | Good, established | Generally enhanced due to thinner struts |
| Common use case | Routine PCI, bare-metal and DES platforms | Widely used base for modern DES platforms |
| Clinical track record | Long-established | Increasingly the standard for newer platforms |
Both materials are biocompatible and used in CE-marked devices, and the choice reflects lesion characteristics and physician preference rather than one material being universally superior.
Why Might a Physician Choose One Material Over the Other?
The decision between a stainless-steel and cobalt-chromium stent depends on factors such as vessel size, lesion tortuosity, calcification, and whether a drug-eluting coating is planned. Cobalt-chromium's thinner-strut capability is often favored for complex or tortuous anatomy, while stainless steel remains a dependable option for many routine cases. This determination is made by the interventional cardiologist based on the individual patient's angiographic findings.
Frequently Asked Questions
Is cobalt-chromium always better than stainless steel for stents?
Not necessarily "better" in a universal sense; cobalt-chromium's thinner-strut profile offers certain deliverability and vessel-coverage advantages, but stainless steel remains a clinically valid material with its own established track record. Appropriateness depends on the specific case.
Does strut thickness affect the risk of restenosis?
Thinner struts are generally associated with reduced vessel wall injury and, in some studies, lower rates of restenosis, though many other factors, including drug coating and lesion characteristics, also play a significant role. A cardiologist can explain the relevant considerations for an individual case.
Are both stent materials CE marked for use in Europe?
Stent devices intended for the European market are required to carry CE marking under EU MDR 2017/745, though specific indications and availability can vary by country and device. Patients should confirm details with their care team and the product's official Instructions for Use.
Related INVAMED Resources
- ATLAS Drug Eluting Coronary Stent System Cobalt Chromium
- Atlas Coronary Stent System Stainless Steel
- Coronary Artery Disease & Cardiac Interventions
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.